Developmental pharmacokinetics of antibiotics used in neonatal ICU: focus on preterm infants

OI Butranova, EA Ushkalova, SK Zyryanov… - Biomedicines, 2023 - mdpi.com
Neonatal Infections are among the most common reasons for admission to the intensive
care unit. Neonatal sepsis (NS) significantly contributes to mortality rates. Empiric antibiotic …

Epigenetic mechanisms contribute to intraindividual variations of drug metabolism mediated by cytochrome P450 enzymes

J Jin, X Zhong - Drug Metabolism and Disposition, 2023 - ASPET
Significant interindividual and intraindividual variations on cytochrome P450 (CYP)-
mediated drug metabolism exist in the general population globally. Genetic polymorphisms …

Physiologically based pharmacokinetics modeling in the neonatal population—current advances, challenges, and opportunities

J Dinh, TN Johnson, M Grimstein, T Lewis - Pharmaceutics, 2023 - mdpi.com
Physiologically based pharmacokinetic (PBPK) modeling is an approach to predicting drug
pharmacokinetics, using knowledge of the human physiology involved and drug …

Personalizing atomoxetine dosing in children with ADHD: what can we learn from current supporting evidence

D Fu, HL Guo, YH Hu, WR Fang, QQ Liu, J Xu… - European Journal of …, 2023 - Springer
Purpose There is marked heterogeneity in treatment response of atomoxetine in patients
with attention deficit/hyperactivity disorder (ADHD), especially for the pediatric population …

Practice of CYP450 genotyping and phenotyping in children in a real-life setting

F Rodieux, Y Daali, V Rollason, CF Samer… - Frontiers in …, 2023 - frontiersin.org
Pharmacokinetics varies widely between children. Many factors play an important role in this
variability, such as ontogeny, pharmacogenetics, gender, comorbidities, and drug-drug …

Successful Management of Fetal Torsades de Pointes and Long QT Syndrome by a Cardio-Obstetrical Team

M Putra, YM Lee, E Bucholz, EL Ross, H Galan… - Case Reports, 2023 - jacc.org
A 32-week fetus with tachycardia and bradycardia, diagnosed with torsades de pointes,
atrioventricular block, and sinus bradycardia due to a de novo KCNH2 mutation was …

Case report: Use of therapeutic drug monitoring and pharmacogenetic testing as opportunities to individualize care in a case of flecainide toxicity after fetal …

R Palmen, T Sandritter, L Malloy-Walton… - Frontiers in …, 2023 - frontiersin.org
Flecainide is a class IC antiarrhythmic utilized in prophylaxis of refractory paroxysmal
supraventricular tachycardias in pediatric populations. Despite being a highly effective …

[PDF][PDF] The Clinical Application of Pharmacogenetics in Understanding Drug Response

PS Kee - 2023 - ourarchive.otago.ac.nz
Pharmacogenetics focuses on heritable factors that influence drug responses. For a given
drug and patient, pharmacogenetics aims to optimise the intended therapeutic benefits …